• Users Online: 219
  • Print this page
  • Email this page


 
 
Table of Contents
CME TEST
Year : 2019  |  Volume : 30  |  Issue : 2  |  Page : 89-90

Cme test


Date of Web Publication28-Mar-2019

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1879-5226.235386

Get Permissions


How to cite this article:
. Cme test. Urol Sci 2019;30:89-90

How to cite this URL:
. Cme test. Urol Sci [serial online] 2019 [cited 2019 Apr 23];30:89-90. Available from: http://www.e-urol-sci.com/text.asp?2019/30/2/89/235386




  Cme Test Top


Please read this issue of Urological Science and return the postage-paid reply slip with your answers by June, 2019. A score of 80% or better will earn three CME credits. Questions/answers:

  1. Based on the retrospective study for non-muscle invasive bladder cancer, which statement is correct?


    1. The efficacy of BCG is poorer than mitomycin in terms of the prevention of tumor recurrence.
    2. The efficacy of BCG is poorer than mitomycin in terms of tumor progression.
    3. The efficacy of BCG is poorer than mitomycin in terms of overall survival.
    4. This study is limited by the retrospective nature. Based on this limited information, BCG might be better than mitomycin in terms of reducing tumor recurrence.
    5. None of the above.


    Urol Sci 2019;30(2):67-73.

  2. Which is the objective criterion for evaluating uroflow pattern in the article (UROS_100_18R2)?


    1. Franco-Yang (F-Y) index (≧50)
    2. Angle at peak flow rate (A_Qmax ≧50°)
    3. Franco-Yang (F-Y) index (≧80)
    4. Angle at peak flow rate (A_Qmax <80°)
    5. All of the above


    Urol Sci 2019;30(2):74-78.

  3. According to the experience of Mackay Memorial Hospital, which statement is correct?


    1. The symptom-to-treatment time was found to be an independent predictor of improvements in renal function.
    2. The symptom-to-treatment time was found to be an independent predictor of improvements in hydronephrosis.
    3. Early diagnosis and prompt internal ureteral stenting can not prevent renal loss.
    4. The symptom-to-treatment time was not linearly associated with pre- and posttreatment hydronephrosis grade.
    5. None of the above.


    Urol Sci 2019;30(2):79-83.

  4. Which statement about autophagy modulation is correct?


    1. The catabolic process of autophagy is an essential cellular function that directs the breakdown and recycling of cellular macromolecules.
    2. Cancer cells with rapid proliferation require a high basal level of autophagy.
    3. The regulation of autophagy by a class of small noncoding microRNAs (miRNAs) in human cancer has been discovered in recent years.
    4. In bladder cancer, a high basal level of autophagy plays critical roles in cancer survival and resistance to chemotherapy.
    5. All of the above.


    Urol Sci 2019;30(2):46-52.

  5. Which statement is correct for bladder stones in Taiwan?


    1. The admission rate for bladder calculi is 12.9/100,000 in 2010.
    2. Pediatric bladder stones are very rare in Taiwan.
    3. The four most common causes of secondary bladder calculi are bladder outlet obstruction (BOO), neurogenic bladder, intravesical foreign bodies, and renal transplant.
    4. Contemporary treatment of bladder calculi includes endoscopic cystolithotripsy or cystolitholapaxy with laser or LithoClast lithotripters.
    5. All of the above.


Urol Sci 2019;30(2):53-57.

Volume 30 Issue 1

Answers:

1. (C) 2. (D) 3. (D) 4. (E) 5. (C)






 

Top
 
  Search
 
    Similar in PUBMED
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Cme Test

 Article Access Statistics
    Viewed36    
    Printed1    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal